Engineering HSV-1 for Gene Therapy, Oncolytic Immunotherapy, and Neuroscience.
This review illustrates how HSV-1 has evolved from a naturally neurotropic virus into a versatile biomedical tool, whose therapeutic and research potential emerges from the precise matching of viral properties with disease-specific requirements, delivery contexts, and functional objectives.
Bo Yang, Zhi-Yu Liu, Feng Xiong et al.
· Virologica Sinica · 0 citations